戴维医疗收盘上涨1.14%，滚动市盈率103.88倍，总市值43.34亿元

Core Viewpoint - David Medical's stock closed at 15.05 yuan, with a PE ratio of 103.88 times, significantly higher than the industry average of 59.49 times, indicating potential overvaluation in the context of its financial performance [1][2] Company Summary - David Medical specializes in obstetric and pediatric care equipment, minimally invasive surgical instruments, and emergency ICU products, with key products including incubators, warming devices, jaundice treatment equipment, and various monitoring devices [1] - The company has received multiple accolades, including recognition as a "Manufacturing Industry Single Champion Cultivation Enterprise" by the Ministry of Industry and Information Technology, and has been awarded "Zhejiang Province Famous Trademark" and "AAA Credit Rating Enterprise" [1] Financial Performance - For Q1 2025, the company reported revenue of 121 million yuan, a year-on-year decrease of 22.00%, and a net profit of 22.57 million yuan, down 40.78% from the previous year, with a gross margin of 57.13% [2] - The company's PE ratio (TTM) stands at 103.88, while the industry average is 59.49, indicating a significant premium on its valuation compared to peers [2]